Search Results 481-490 of 17430 for PCOS benefits

1. Medical Research & Education - Mayo Clinic News Network

   — Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a "one-size-fits-all" remedy, Mayo Clinic researchers have[.

2. A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls - Mayo Clinic

   The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with T1D ...

3. ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

4. Study Evaluating The Efficacy And Safety Of Artesunate - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

5. A Study to Evaluate Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having Heart Failure with Preserved Ejection Fraction - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the ... benefit observed with empagliflozin varies according to baseline health status.

6. Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

7. Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

8. Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

9. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

10. Medical Research & Education - Mayo Clinic News Network

    Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet. Clinical Trials. Largest ...